news Mercopress 2026-08-19

Personalized mRNA cancer therapy achieves milestone in phase 3 trial

Merck and Moderna announced successful phase 3 clinical results for a personalized mRNA vaccine treating melanoma, marking a first for cancer treatment.

Support Your Local Toad

The Pesky Toad is free and ad-light. If you find it useful, toss a few pesos in the tip jar to help keep the servers running and the satire flowing.

$

MXN · Minimum $10